Medical Genomics: Drivers and Potential for Disruptive Change in Personized Medicine

Medical Genomics: Drivers and Potential for Disruptive Change in Personized Medicine

Loading
Loading Social Plug-ins...
Language: English
Save to myLibrary Post page as Slide Download PDF
Go to Page # Page of 26

Description: Personalized Genomic Medicine, Genetics in Medicine 2011, Whole Genome Analysis as a Universal Diagnostic, Futuristic Paradigm for Cancer Care, Sequence Analyses of Tumor to Guide Therapy, Potential Workforces for Personalized Genomic Medicine.

 
Author: Mark S. Boguski, M.D. (Fellow) | Visits: 1368 | Page Views: 3863
Domain:  Medicine Category: Therapy Subcategory: Genomics 
Upload Date:
Link Back:
Short URL: http://medical.wesrch.com/pdfME1LYYSIBCRLH

Loading
Loading...



px *        px *

* Default width and height in pixels. Change it to your required dimensions.

 
Maxims of Tech: Rules of Engagement for a Fast Changing Environment
Contents:
Personalized Genomic Medicine
Mark S. Boguski, M.D., Ph.D., F.C.A.P. Center for Biomedical Informatics, Harvard Medical School Department of Pathology, BIDMC July 19, 2011

"[a patient's genome] is just another lab value."
-- D.P. Dimmock ACMG, Vancouver 18 March 2011

Genetics in Medicine 2011; 13(3):255-262

Medical Genomics: Drivers and Potential for Disruptive Change
Time Period 1998-2003 2003-2009 2010-2011 Genomes
1. 2. NIH reference Celera reference

Turn-around time ~5 years ~6 months 4-6 weeks

FTEs ~2,000 Dozens 3-4

Cost per genome ~$2-3 billion $300,00038,000 $ 6,000 exome $ 9,500 genome $5,000$1,000

~10 additional 103-104

2012-2014

105

2 weeks

2

2015-2020

Millions

Hours?

Subscribe
x